Corcept Therapeutics, Inc. (CORT)
34.73
-0.66
(-1.86%)
USD |
NASDAQ |
Jan 16, 16:00
34.77
+0.04
(+0.12%)
After-Hours: 20:00
Corcept Therapeutics Shareholders Equity (Quarterly): 631.90M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 73.73M |
| Johnson & Johnson | 79.28B |
| United Therapeutics Corp. | 6.590B |
| Ultragenyx Pharmaceutical, Inc. | 9.159M |
| Amicus Therapeutics, Inc. | 230.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 823.61M |
| Total Liabilities (Quarterly) | 191.70M |
| Debt to Equity Ratio | 0.0101 |
| Current Ratio | 3.141 |
| Net Debt Paydown Yield | -0.00% |